MedTrace Logo

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

NCT01267305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 362

Last updated 2014-04-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether the use of different dose of LMWH compared with fondaparinux for thromboprophylaxis is efficacious and safety after thoracic surgery.

Conditions

  • Lung Neoplasms
  • Esophageal Neoplasms
  • Venous Thromboembolism

Interventions

DRUG

Fondaparinux

2.5mg IH qd(8AM) after operation

DRUG

Nadroparin Calcium

4100AxaIU IH qd(8AM) after operation

DRUG

Nadroparin Calcium

4100AxaIU IH q12h(8Am,8Pm) after operation

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Lizhen Xuan · Shanghai Zhongshan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-04-30
Completion
2013-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01267305 on ClinicalTrials.gov